Customer Publication

Applications of Label-free, Quantitative Phase Holographic Imaging Cytometry to the Development of Multi-specific Nanoscale Pharmaceutical Formulations

Authors: E. Luther et al.

Journal: Cytometry Part A 2017 (2017)

Institution: Northeastern University

Cell Lines: HeLa, L929 (HeLa:Human cervical cancer; L929: mouse fibroblast)

Summary: A review of HoloMonitor applications: tracking of Giant HeLa cells, which may be undergoing neosis tracking the effects of cell cycle-related toxic agents on cell lines; using MicroRNAs to reverse the polarization state in macrophages to induce tumor cell killing the development of liposomal nanoformulations to overcome multidrug resistance in ovarian cancer cells and development of dual sensitive micelles to specifically target matrix metalloproteinase,

Keywords: Review, HoloMonitor M4, Holographic imaging, Label-free, Time-lapse, 4-D imaging

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
+46 46 38 60 80

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
+1 617-963-5150


VAT: SE556542781101

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2